China’s National Health Commission has said that Aluvia, which is designed to treat HIV, is a possible treatment for the symptoms of the coronavirus. Aluvia works by blocking an enzyme that the coronavirus needs to reproduce.
One coronavirus patient told China’s Time-Weekly that Aluvia seemed to be effective for him, according to Endpoints News.
Aluvia has previously been tested in patients with SARS and MERS, other types of coronaviruses.
However, Aluvia is hard to get in China, a Wuhan physician told Time-Weekly.
In response, AbbVie said it will donate $1.44 million worth of the pills, but didn’t specify how it would distribute them, Endpoints News reported.
Read the full article here.
More articles on pharmacy:
BCBS, Civica Rx create subsidiary to cut generic drug costs
PhRMA spent a record $29M on lobbying in 2019
Former Insys CEO gets 30 months in prison
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
